THL Credit Senior Loan Fund  

(Public, NYSE:TSLF)   Watch this stock  
Find more results for Jennifer L. Wilson
0.00 (0.00%)
Feb 10 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 14.41 - 14.68
52 week 14.29 - 19.49
Open 14.46
Vol / Avg. 9,858.00/31,591.00
Mkt cap 107.80M
P/E     -
Div/yield     -/9.10
EPS     -
Shares 7.42M
Beta     -
Inst. own     -


100 Wall St Fl 11
NEW YORK, NY 10005-3701
United States - Map
+1-212-7014500 (Phone)
+1-302-6555049 (Fax)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


THL Credit Senior Loan Fund is a non-diversified, closed-end management investment company (Fund). The Fund's investment objective is to provide current income and preservation of capital primarily through investments in United States dollar-denominated senior secured corporate loans and notes. Under normal market conditions, the Fund will invest 100% of its Managed Assets in the securities of issuers located in North America and does not currently intend to invest a material amount of its Managed Assets outside the United States. It invests in sectors, such as Business, Services, Healthcare and Pharmaceuticals, Retail, Software, Advertising, Printing and Publishing, and Diversified and Services, among others. Four Wood Capital Advisors LLC serves as the Fund's investment adviser.

Officers and directors

Joseph L. Morea Independent Chairman, Trustee
Age: 60
Bio & Compensation  - Reuters
Steven A. Baffico President, Principal Executive Officer, Trustee
Age: 42
Bio & Compensation  - Reuters
Jennifer Wilson Principal Financial Officer, Principal Accounting Officer, Treasurer
Age: 43
Bio & Compensation  - Reuters
Robert Cowles Chief Compliance Officer
Age: 39
Bio & Compensation  - Reuters
Stephanie Trell Secretary
Age: 47
Bio & Compensation  - Reuters
Ronald J. Burton Independent Trustee
Age: 68
Bio & Compensation  - Reuters
S. James Coppersmith Independent Trustee
Age: 82
Bio & Compensation  - Reuters
Michael Perino Independent Trustee
Age: 52
Bio & Compensation  - Reuters